nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—hematopoietic system—hematologic cancer	0.0167	0.0768	CbGeAlD
Alendronate—PTPN4—hematopoietic system—hematologic cancer	0.0159	0.073	CbGeAlD
Alendronate—PTPRE—blood—hematologic cancer	0.0111	0.0509	CbGeAlD
Alendronate—PTPRE—bone marrow—hematologic cancer	0.0107	0.0492	CbGeAlD
Alendronate—PTPN4—blood—hematologic cancer	0.0105	0.0484	CbGeAlD
Alendronate—PTPN4—bone marrow—hematologic cancer	0.0102	0.0468	CbGeAlD
Alendronate—PTPRE—lung—hematologic cancer	0.00972	0.0446	CbGeAlD
Alendronate—PTPN4—lung—hematologic cancer	0.00925	0.0424	CbGeAlD
Alendronate—PTPRE—testis—hematologic cancer	0.00917	0.0421	CbGeAlD
Alendronate—PTPRS—bone marrow—hematologic cancer	0.00875	0.0401	CbGeAlD
Alendronate—PTPN4—testis—hematologic cancer	0.00872	0.04	CbGeAlD
Alendronate—PTPRS—lung—hematologic cancer	0.00792	0.0364	CbGeAlD
Alendronate—ATP6V1A—hematopoietic system—hematologic cancer	0.00787	0.0361	CbGeAlD
Alendronate—PTPRS—testis—hematologic cancer	0.00748	0.0343	CbGeAlD
Alendronate—PTPRE—lymph node—hematologic cancer	0.00665	0.0305	CbGeAlD
Alendronate—PTPN4—lymph node—hematologic cancer	0.00632	0.029	CbGeAlD
Alendronate—ATP6V1A—gonad—hematologic cancer	0.00598	0.0274	CbGeAlD
Alendronate—FDPS—hematopoietic system—hematologic cancer	0.00593	0.0272	CbGeAlD
Alendronate—PTPRS—lymph node—hematologic cancer	0.00542	0.0249	CbGeAlD
Alendronate—ATP6V1A—blood—hematologic cancer	0.00521	0.0239	CbGeAlD
Alendronate—ATP6V1A—bone marrow—hematologic cancer	0.00504	0.0231	CbGeAlD
Alendronate—ATP6V1A—lung—hematologic cancer	0.00457	0.021	CbGeAlD
Alendronate—FDPS—gonad—hematologic cancer	0.00451	0.0207	CbGeAlD
Alendronate—ATP6V1A—testis—hematologic cancer	0.00431	0.0198	CbGeAlD
Alendronate—FDPS—blood—hematologic cancer	0.00393	0.018	CbGeAlD
Alendronate—FDPS—bone marrow—hematologic cancer	0.0038	0.0174	CbGeAlD
Alendronate—FDPS—lung—hematologic cancer	0.00344	0.0158	CbGeAlD
Alendronate—FDPS—testis—hematologic cancer	0.00325	0.0149	CbGeAlD
Alendronate—ATP6V1A—lymph node—hematologic cancer	0.00313	0.0143	CbGeAlD
Alendronate—FDPS—lymph node—hematologic cancer	0.00235	0.0108	CbGeAlD
Alendronate—Histamine Phosphate—SLC22A1—hematologic cancer	0.000858	1	CrCbGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL17—hematologic cancer	0.000189	0.000851	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGRN—hematologic cancer	0.000189	0.000851	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT5B—hematologic cancer	0.000188	0.000845	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NUP98—hematologic cancer	0.000188	0.000845	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCR5—hematologic cancer	0.000185	0.000835	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FHL2—hematologic cancer	0.000184	0.000829	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CST3—hematologic cancer	0.000184	0.000826	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADCY7—hematologic cancer	0.000182	0.00082	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEF1—hematologic cancer	0.000182	0.00082	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NUP214—hematologic cancer	0.000181	0.000815	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AGRN—hematologic cancer	0.000181	0.000813	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNA13—hematologic cancer	0.000179	0.000806	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTR—hematologic cancer	0.000177	0.000798	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—XIAP—hematologic cancer	0.000177	0.000798	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TIAM1—hematologic cancer	0.000176	0.000793	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ENO2—hematologic cancer	0.000174	0.000783	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMARCA4—hematologic cancer	0.000173	0.000778	CbGpPWpGaD
Alendronate—FDPS—Metabolism—IDH2—hematologic cancer	0.000171	0.000771	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMMR—hematologic cancer	0.000171	0.000771	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAK3—hematologic cancer	0.000171	0.000769	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SDC1—hematologic cancer	0.000165	0.000742	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL13—hematologic cancer	0.000164	0.000737	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR7—hematologic cancer	0.000164	0.000737	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NCOR2—hematologic cancer	0.000162	0.000728	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000162	0.000727	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ARNTL—hematologic cancer	0.000161	0.000725	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CRKL—hematologic cancer	0.00016	0.000719	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL3RA—hematologic cancer	0.00016	0.000719	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LCK—hematologic cancer	0.00016	0.000719	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA9—hematologic cancer	0.000157	0.000705	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACP5—hematologic cancer	0.000157	0.000705	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—H3F3A—hematologic cancer	0.000157	0.000704	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOR2—hematologic cancer	0.000155	0.000696	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RGS2—hematologic cancer	0.000154	0.000693	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CMA1—hematologic cancer	0.000152	0.000686	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TRIO—hematologic cancer	0.000152	0.000686	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TRH—hematologic cancer	0.000152	0.000686	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKCZ—hematologic cancer	0.000152	0.000685	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CALR—hematologic cancer	0.000149	0.000673	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SPHK1—hematologic cancer	0.000149	0.000671	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGO2—hematologic cancer	0.000149	0.000671	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HDAC9—hematologic cancer	0.000148	0.000664	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LPAR1—hematologic cancer	0.000148	0.000664	CbGpPWpGaD
Alendronate—FDPS—Metabolism—IDH1—hematologic cancer	0.000147	0.000663	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PARP1—hematologic cancer	0.000147	0.000661	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—H3F3B—hematologic cancer	0.000146	0.000657	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCC3—hematologic cancer	0.000146	0.000655	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TXN—hematologic cancer	0.000146	0.000655	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTO1—hematologic cancer	0.000146	0.000655	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FBXW7—hematologic cancer	0.000145	0.000651	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SPHK1—hematologic cancer	0.000143	0.000641	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HDAC2—hematologic cancer	0.000142	0.000638	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CXCR4—hematologic cancer	0.000142	0.000638	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD44—hematologic cancer	0.00014	0.000631	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CBL—hematologic cancer	0.000138	0.000622	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UGT1A1—hematologic cancer	0.000137	0.000616	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDE4B—hematologic cancer	0.000136	0.000611	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CNR2—hematologic cancer	0.000136	0.000611	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF19—hematologic cancer	0.000135	0.000606	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RAC2—hematologic cancer	0.000134	0.000601	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CRABP1—hematologic cancer	0.000133	0.0006	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC22A1—hematologic cancer	0.000133	0.0006	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DKK1—hematologic cancer	0.000133	0.000596	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000132	0.000595	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HSP90AA1—hematologic cancer	0.000132	0.000593	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT5B—hematologic cancer	0.000131	0.000592	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALOX5—hematologic cancer	0.00013	0.000584	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADCY7—hematologic cancer	0.000128	0.000575	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT1—hematologic cancer	0.000127	0.000572	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NUP98—hematologic cancer	0.000126	0.000566	CbGpPWpGaD
Alendronate—Feeling abnormal—Etoposide—hematologic cancer	0.000125	0.000223	CcSEcCtD
Alendronate—Diarrhoea—Mitoxantrone—hematologic cancer	0.000125	0.000223	CcSEcCtD
Alendronate—Diarrhoea—Irinotecan—hematologic cancer	0.000125	0.000223	CcSEcCtD
Alendronate—Vomiting—Carmustine—hematologic cancer	0.000124	0.000223	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—XIAP—hematologic cancer	0.000124	0.000559	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Etoposide—hematologic cancer	0.000124	0.000221	CcSEcCtD
Alendronate—Infection—Dexamethasone—hematologic cancer	0.000124	0.000221	CcSEcCtD
Alendronate—Infection—Betamethasone—hematologic cancer	0.000124	0.000221	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000124	0.000557	CbGpPWpGaD
Alendronate—Dizziness—Vincristine—hematologic cancer	0.000124	0.000221	CcSEcCtD
Alendronate—Rash—Carmustine—hematologic cancer	0.000123	0.000221	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—hematologic cancer	0.000123	0.000221	CcSEcCtD
Alendronate—Dermatitis—Carmustine—hematologic cancer	0.000123	0.000221	CcSEcCtD
Alendronate—Vomiting—Alitretinoin—hematologic cancer	0.000123	0.000221	CcSEcCtD
Alendronate—Feeling abnormal—Prednisolone—hematologic cancer	0.000123	0.00022	CcSEcCtD
Alendronate—Anaemia—Prednisone—hematologic cancer	0.000123	0.00022	CcSEcCtD
Alendronate—Headache—Carmustine—hematologic cancer	0.000123	0.000219	CcSEcCtD
Alendronate—Rash—Alitretinoin—hematologic cancer	0.000122	0.000219	CcSEcCtD
Alendronate—Dermatitis—Alitretinoin—hematologic cancer	0.000122	0.000219	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000122	0.000218	CcSEcCtD
Alendronate—FDPS—Metabolism—ADCY7—hematologic cancer	0.000122	0.000549	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA3—hematologic cancer	0.000122	0.000549	CbGpPWpGaD
Alendronate—Vomiting—Ifosfamide—hematologic cancer	0.000122	0.000218	CcSEcCtD
Alendronate—Hypersensitivity—Cisplatin—hematologic cancer	0.000122	0.000218	CcSEcCtD
Alendronate—Headache—Alitretinoin—hematologic cancer	0.000122	0.000217	CcSEcCtD
Alendronate—Angioedema—Prednisone—hematologic cancer	0.000121	0.000217	CcSEcCtD
Alendronate—Diarrhoea—Gemcitabine—hematologic cancer	0.000121	0.000217	CcSEcCtD
Alendronate—FDPS—Metabolism—NUP214—hematologic cancer	0.000121	0.000545	CbGpPWpGaD
Alendronate—Nausea—Thalidomide—hematologic cancer	0.000121	0.000217	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—SH2B3—hematologic cancer	0.000121	0.000545	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SMARCA4—hematologic cancer	0.000121	0.000545	CbGpPWpGaD
Alendronate—Dyspepsia—Triamcinolone—hematologic cancer	0.000121	0.000216	CcSEcCtD
Alendronate—Rash—Ifosfamide—hematologic cancer	0.000121	0.000216	CcSEcCtD
Alendronate—Dermatitis—Ifosfamide—hematologic cancer	0.000121	0.000216	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—hematologic cancer	0.000121	0.000216	CcSEcCtD
Alendronate—Dizziness—Irinotecan—hematologic cancer	0.00012	0.000215	CcSEcCtD
Alendronate—Urticaria—Etoposide—hematologic cancer	0.00012	0.000215	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GZMB—hematologic cancer	0.00012	0.000541	CbGpPWpGaD
Alendronate—Haemoglobin—Epirubicin—hematologic cancer	0.00012	0.000215	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—hematologic cancer	0.00012	0.000215	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.00012	0.00054	CbGpPWpGaD
Alendronate—Malaise—Prednisone—hematologic cancer	0.00012	0.000215	CcSEcCtD
Alendronate—Abdominal pain—Etoposide—hematologic cancer	0.00012	0.000214	CcSEcCtD
Alendronate—Body temperature increased—Etoposide—hematologic cancer	0.00012	0.000214	CcSEcCtD
Alendronate—Vertigo—Prednisone—hematologic cancer	0.000119	0.000214	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—hematologic cancer	0.000119	0.000214	CcSEcCtD
Alendronate—ATP6V1A—Disease—GRB2—hematologic cancer	0.000119	0.000535	CbGpPWpGaD
Alendronate—Vomiting—Vincristine—hematologic cancer	0.000119	0.000213	CcSEcCtD
Alendronate—FDPS—Metabolism—MTR—hematologic cancer	0.000119	0.000534	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG2—hematologic cancer	0.000119	0.000534	CbGpPWpGaD
Alendronate—Urticaria—Prednisolone—hematologic cancer	0.000119	0.000212	CcSEcCtD
Alendronate—ATP6V1A—Disease—PDGFA—hematologic cancer	0.000119	0.000534	CbGpPWpGaD
Alendronate—Asthenia—Cisplatin—hematologic cancer	0.000119	0.000212	CcSEcCtD
Alendronate—Rash—Vincristine—hematologic cancer	0.000118	0.000211	CcSEcCtD
Alendronate—Dermatitis—Vincristine—hematologic cancer	0.000118	0.000211	CcSEcCtD
Alendronate—Oedema peripheral—Epirubicin—hematologic cancer	0.000118	0.000211	CcSEcCtD
Alendronate—Pain—Triamcinolone—hematologic cancer	0.000117	0.00021	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CTNNA1—hematologic cancer	0.000117	0.000528	CbGpPWpGaD
Alendronate—Headache—Vincristine—hematologic cancer	0.000117	0.000209	CcSEcCtD
Alendronate—ATP6V1A—Disease—KITLG—hematologic cancer	0.000117	0.000526	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HSPB1—hematologic cancer	0.000117	0.000525	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000117	0.000525	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL3—hematologic cancer	0.000117	0.000525	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO2—hematologic cancer	0.000116	0.000524	CbGpPWpGaD
Alendronate—Nausea—Carmustine—hematologic cancer	0.000116	0.000208	CcSEcCtD
Alendronate—Vomiting—Mitoxantrone—hematologic cancer	0.000116	0.000207	CcSEcCtD
Alendronate—Vomiting—Irinotecan—hematologic cancer	0.000116	0.000207	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—hematologic cancer	0.000115	0.00052	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SDC1—hematologic cancer	0.000115	0.00052	CbGpPWpGaD
Alendronate—Nausea—Alitretinoin—hematologic cancer	0.000115	0.000206	CcSEcCtD
Alendronate—Rash—Irinotecan—hematologic cancer	0.000115	0.000205	CcSEcCtD
Alendronate—Rash—Mitoxantrone—hematologic cancer	0.000115	0.000205	CcSEcCtD
Alendronate—Dermatitis—Mitoxantrone—hematologic cancer	0.000115	0.000205	CcSEcCtD
Alendronate—Dermatitis—Irinotecan—hematologic cancer	0.000115	0.000205	CcSEcCtD
Alendronate—ATP6V1A—Disease—STAT5A—hematologic cancer	0.000114	0.000514	CbGpPWpGaD
Alendronate—Headache—Irinotecan—hematologic cancer	0.000114	0.000204	CcSEcCtD
Alendronate—Headache—Mitoxantrone—hematologic cancer	0.000114	0.000204	CcSEcCtD
Alendronate—Nausea—Ifosfamide—hematologic cancer	0.000114	0.000204	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000114	0.000203	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000114	0.000203	CcSEcCtD
Alendronate—ATP6V1A—Disease—CDKN2B—hematologic cancer	0.000113	0.00051	CbGpPWpGaD
Alendronate—Myalgia—Prednisone—hematologic cancer	0.000113	0.000203	CcSEcCtD
Alendronate—Feeling abnormal—Triamcinolone—hematologic cancer	0.000113	0.000202	CcSEcCtD
Alendronate—Diarrhoea—Cisplatin—hematologic cancer	0.000113	0.000202	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—hematologic cancer	0.000113	0.000202	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTT1—hematologic cancer	0.000113	0.000508	CbGpPWpGaD
Alendronate—Alopecia—Methotrexate—hematologic cancer	0.000113	0.000202	CcSEcCtD
Alendronate—Vomiting—Gemcitabine—hematologic cancer	0.000113	0.000202	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTGER4—hematologic cancer	0.000112	0.000506	CbGpPWpGaD
Alendronate—Discomfort—Prednisone—hematologic cancer	0.000112	0.0002	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—LCK—hematologic cancer	0.000112	0.000503	CbGpPWpGaD
Alendronate—Rash—Gemcitabine—hematologic cancer	0.000112	0.0002	CcSEcCtD
Alendronate—Dermatitis—Gemcitabine—hematologic cancer	0.000112	0.0002	CcSEcCtD
Alendronate—Hypersensitivity—Etoposide—hematologic cancer	0.000112	0.0002	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000111	0.0005	CbGpPWpGaD
Alendronate—Erythema—Methotrexate—hematologic cancer	0.000111	0.000199	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—hematologic cancer	0.000111	0.000199	CcSEcCtD
Alendronate—Headache—Gemcitabine—hematologic cancer	0.000111	0.000199	CcSEcCtD
Alendronate—Nausea—Vincristine—hematologic cancer	0.000111	0.000199	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—hematologic cancer	0.000111	0.000198	CcSEcCtD
Alendronate—FDPS—Metabolism—SDC1—hematologic cancer	0.00011	0.000497	CbGpPWpGaD
Alendronate—Hypersensitivity—Prednisolone—hematologic cancer	0.00011	0.000197	CcSEcCtD
Alendronate—Dyspepsia—Betamethasone—hematologic cancer	0.00011	0.000196	CcSEcCtD
Alendronate—Dyspepsia—Dexamethasone—hematologic cancer	0.00011	0.000196	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—H3F3A—hematologic cancer	0.00011	0.000493	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD86—hematologic cancer	0.00011	0.000493	CbGpPWpGaD
Alendronate—Urticaria—Triamcinolone—hematologic cancer	0.000109	0.000195	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—hematologic cancer	0.000109	0.000195	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—hematologic cancer	0.000109	0.000195	CcSEcCtD
Alendronate—Asthenia—Etoposide—hematologic cancer	0.000109	0.000194	CcSEcCtD
Alendronate—Body temperature increased—Triamcinolone—hematologic cancer	0.000109	0.000194	CcSEcCtD
Alendronate—Nausea—Mitoxantrone—hematologic cancer	0.000108	0.000193	CcSEcCtD
Alendronate—Nausea—Irinotecan—hematologic cancer	0.000108	0.000193	CcSEcCtD
Alendronate—ATP6V1A—Disease—HES1—hematologic cancer	0.000108	0.000486	CbGpPWpGaD
Alendronate—Infection—Prednisone—hematologic cancer	0.000108	0.000193	CcSEcCtD
Alendronate—ATP6V1A—Disease—NCOR1—hematologic cancer	0.000107	0.000484	CbGpPWpGaD
Alendronate—Pruritus—Etoposide—hematologic cancer	0.000107	0.000192	CcSEcCtD
Alendronate—Pain—Dexamethasone—hematologic cancer	0.000107	0.000191	CcSEcCtD
Alendronate—Pain—Betamethasone—hematologic cancer	0.000107	0.000191	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PRKCZ—hematologic cancer	0.000107	0.00048	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF1—hematologic cancer	0.000106	0.000478	CbGpPWpGaD
Alendronate—Alopecia—Epirubicin—hematologic cancer	0.000106	0.000189	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000105	0.000475	CbGpPWpGaD
Alendronate—Nausea—Gemcitabine—hematologic cancer	0.000105	0.000188	CcSEcCtD
Alendronate—Vomiting—Cisplatin—hematologic cancer	0.000105	0.000188	CcSEcCtD
Alendronate—ATP6V1A—Disease—FOXO1—hematologic cancer	0.000105	0.000471	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFRB—hematologic cancer	0.000105	0.00047	CbGpPWpGaD
Alendronate—Erythema multiforme—Doxorubicin—hematologic cancer	0.000105	0.000187	CcSEcCtD
Alendronate—Rash—Cisplatin—hematologic cancer	0.000104	0.000186	CcSEcCtD
Alendronate—Dermatitis—Cisplatin—hematologic cancer	0.000104	0.000186	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000104	0.000468	CbGpPWpGaD
Alendronate—Erythema—Epirubicin—hematologic cancer	0.000104	0.000186	CcSEcCtD
Alendronate—Diarrhoea—Etoposide—hematologic cancer	0.000104	0.000185	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—hematologic cancer	0.000103	0.000184	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PARP1—hematologic cancer	0.000103	0.000463	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFRA—hematologic cancer	0.000103	0.000463	CbGpPWpGaD
Alendronate—Anaemia—Methotrexate—hematologic cancer	0.000103	0.000184	CcSEcCtD
Alendronate—Feeling abnormal—Betamethasone—hematologic cancer	0.000103	0.000184	CcSEcCtD
Alendronate—Feeling abnormal—Dexamethasone—hematologic cancer	0.000103	0.000184	CcSEcCtD
Alendronate—ATP6V1A—Disease—JAK1—hematologic cancer	0.000103	0.000461	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKCG—hematologic cancer	0.000103	0.000461	CbGpPWpGaD
Alendronate—Flatulence—Epirubicin—hematologic cancer	0.000102	0.000183	CcSEcCtD
Alendronate—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000102	0.000182	CcSEcCtD
Alendronate—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000102	0.000182	CcSEcCtD
Alendronate—Dysgeusia—Epirubicin—hematologic cancer	0.000102	0.000182	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FBXW7—hematologic cancer	0.000101	0.000456	CbGpPWpGaD
Alendronate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000101	0.000181	CcSEcCtD
Alendronate—Malaise—Methotrexate—hematologic cancer	0.0001	0.000179	CcSEcCtD
Alendronate—Dizziness—Etoposide—hematologic cancer	0.0001	0.000179	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—hematologic cancer	0.0001	0.000179	CcSEcCtD
Alendronate—Vertigo—Methotrexate—hematologic cancer	9.98e-05	0.000179	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.96e-05	0.000448	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCR4—hematologic cancer	9.93e-05	0.000447	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HDAC2—hematologic cancer	9.93e-05	0.000447	CbGpPWpGaD
Alendronate—Urticaria—Dexamethasone—hematologic cancer	9.9e-05	0.000177	CcSEcCtD
Alendronate—Urticaria—Betamethasone—hematologic cancer	9.9e-05	0.000177	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—hematologic cancer	9.89e-05	0.000177	CcSEcCtD
Alendronate—Dizziness—Prednisolone—hematologic cancer	9.88e-05	0.000177	CcSEcCtD
Alendronate—Asthenia—Triamcinolone—hematologic cancer	9.85e-05	0.000176	CcSEcCtD
Alendronate—Body temperature increased—Dexamethasone—hematologic cancer	9.85e-05	0.000176	CcSEcCtD
Alendronate—Abdominal pain—Betamethasone—hematologic cancer	9.85e-05	0.000176	CcSEcCtD
Alendronate—Body temperature increased—Betamethasone—hematologic cancer	9.85e-05	0.000176	CcSEcCtD
Alendronate—Abdominal pain—Dexamethasone—hematologic cancer	9.85e-05	0.000176	CcSEcCtD
Alendronate—Nausea—Cisplatin—hematologic cancer	9.82e-05	0.000176	CcSEcCtD
Alendronate—Alopecia—Doxorubicin—hematologic cancer	9.77e-05	0.000175	CcSEcCtD
Alendronate—Pruritus—Triamcinolone—hematologic cancer	9.72e-05	0.000174	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CBL—hematologic cancer	9.67e-05	0.000435	CbGpPWpGaD
Alendronate—Ill-defined disorder—Epirubicin—hematologic cancer	9.65e-05	0.000173	CcSEcCtD
Alendronate—Vomiting—Etoposide—hematologic cancer	9.63e-05	0.000172	CcSEcCtD
Alendronate—Erythema—Doxorubicin—hematologic cancer	9.62e-05	0.000172	CcSEcCtD
Alendronate—Anaemia—Epirubicin—hematologic cancer	9.61e-05	0.000172	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—IL3—hematologic cancer	9.57e-05	0.000431	CbGpPWpGaD
Alendronate—Dyspepsia—Prednisone—hematologic cancer	9.55e-05	0.000171	CcSEcCtD
Alendronate—Rash—Etoposide—hematologic cancer	9.55e-05	0.000171	CcSEcCtD
Alendronate—Dermatitis—Etoposide—hematologic cancer	9.54e-05	0.000171	CcSEcCtD
Alendronate—ATP6V1A—Disease—MTHFR—hematologic cancer	9.49e-05	0.000427	CbGpPWpGaD
Alendronate—Headache—Etoposide—hematologic cancer	9.49e-05	0.00017	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—hematologic cancer	9.48e-05	0.00017	CcSEcCtD
Alendronate—ATP6V1A—Disease—TERT—hematologic cancer	9.47e-05	0.000426	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HLA-A—hematologic cancer	9.47e-05	0.000426	CbGpPWpGaD
Alendronate—Chest pain—Methotrexate—hematologic cancer	9.46e-05	0.000169	CcSEcCtD
Alendronate—Myalgia—Methotrexate—hematologic cancer	9.46e-05	0.000169	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—hematologic cancer	9.42e-05	0.000169	CcSEcCtD
Alendronate—Rash—Prednisolone—hematologic cancer	9.42e-05	0.000168	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTPN1—hematologic cancer	9.41e-05	0.000424	CbGpPWpGaD
Alendronate—Dermatitis—Prednisolone—hematologic cancer	9.41e-05	0.000168	CcSEcCtD
Alendronate—FDPS—Metabolism—NQO1—hematologic cancer	9.38e-05	0.000422	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CD44—hematologic cancer	9.38e-05	0.000422	CbGpPWpGaD
Alendronate—Malaise—Epirubicin—hematologic cancer	9.38e-05	0.000168	CcSEcCtD
Alendronate—Headache—Prednisolone—hematologic cancer	9.36e-05	0.000167	CcSEcCtD
Alendronate—Discomfort—Methotrexate—hematologic cancer	9.35e-05	0.000167	CcSEcCtD
Alendronate—Vertigo—Epirubicin—hematologic cancer	9.34e-05	0.000167	CcSEcCtD
Alendronate—Constipation—Prednisone—hematologic cancer	9.28e-05	0.000166	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—RASGRP1—hematologic cancer	9.26e-05	0.000417	CbGpPWpGaD
Alendronate—Muscle spasms—Doxorubicin—hematologic cancer	9.25e-05	0.000165	CcSEcCtD
Alendronate—ATP6V1A—Disease—PDGFB—hematologic cancer	9.24e-05	0.000416	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HSP90AA1—hematologic cancer	9.23e-05	0.000415	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SYK—hematologic cancer	9.23e-05	0.000415	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.19e-05	0.000414	CbGpPWpGaD
Alendronate—Dizziness—Triamcinolone—hematologic cancer	9.08e-05	0.000162	CcSEcCtD
Alendronate—ATP6V1A—Disease—TSC2—hematologic cancer	9.03e-05	0.000407	CbGpPWpGaD
Alendronate—Infection—Methotrexate—hematologic cancer	9.01e-05	0.000161	CcSEcCtD
Alendronate—Nausea—Etoposide—hematologic cancer	8.99e-05	0.000161	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—hematologic cancer	8.94e-05	0.00016	CcSEcCtD
Alendronate—Asthenia—Dexamethasone—hematologic cancer	8.94e-05	0.00016	CcSEcCtD
Alendronate—Asthenia—Betamethasone—hematologic cancer	8.94e-05	0.00016	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—hematologic cancer	8.93e-05	0.00016	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—STAT1—hematologic cancer	8.9e-05	0.000401	CbGpPWpGaD
Alendronate—Anaemia—Doxorubicin—hematologic cancer	8.89e-05	0.000159	CcSEcCtD
Alendronate—FDPS—Metabolism—CYCS—hematologic cancer	8.88e-05	0.0004	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Prednisone—hematologic cancer	8.87e-05	0.000159	CcSEcCtD
Alendronate—Nausea—Prednisolone—hematologic cancer	8.87e-05	0.000159	CcSEcCtD
Alendronate—Chest pain—Epirubicin—hematologic cancer	8.85e-05	0.000158	CcSEcCtD
Alendronate—Myalgia—Epirubicin—hematologic cancer	8.85e-05	0.000158	CcSEcCtD
Alendronate—FDPS—Metabolism—HSP90AA1—hematologic cancer	8.82e-05	0.000397	CbGpPWpGaD
Alendronate—Pruritus—Dexamethasone—hematologic cancer	8.82e-05	0.000158	CcSEcCtD
Alendronate—Pruritus—Betamethasone—hematologic cancer	8.82e-05	0.000158	CcSEcCtD
Alendronate—Discomfort—Epirubicin—hematologic cancer	8.75e-05	0.000156	CcSEcCtD
Alendronate—Vomiting—Triamcinolone—hematologic cancer	8.73e-05	0.000156	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGFR3—hematologic cancer	8.69e-05	0.000391	CbGpPWpGaD
Alendronate—Malaise—Doxorubicin—hematologic cancer	8.68e-05	0.000155	CcSEcCtD
Alendronate—Rash—Triamcinolone—hematologic cancer	8.66e-05	0.000155	CcSEcCtD
Alendronate—Dermatitis—Triamcinolone—hematologic cancer	8.65e-05	0.000155	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—hematologic cancer	8.64e-05	0.000155	CcSEcCtD
Alendronate—Urticaria—Prednisone—hematologic cancer	8.62e-05	0.000154	CcSEcCtD
Alendronate—Headache—Triamcinolone—hematologic cancer	8.6e-05	0.000154	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—hematologic cancer	8.58e-05	0.000153	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—hematologic cancer	8.58e-05	0.000153	CcSEcCtD
Alendronate—Diarrhoea—Betamethasone—hematologic cancer	8.53e-05	0.000153	CcSEcCtD
Alendronate—Diarrhoea—Dexamethasone—hematologic cancer	8.53e-05	0.000153	CcSEcCtD
Alendronate—Infection—Epirubicin—hematologic cancer	8.43e-05	0.000151	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GRB2—hematologic cancer	8.33e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFA—hematologic cancer	8.31e-05	0.000374	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.26e-05	0.000148	CcSEcCtD
Alendronate—Dizziness—Betamethasone—hematologic cancer	8.24e-05	0.000147	CcSEcCtD
Alendronate—Dizziness—Dexamethasone—hematologic cancer	8.24e-05	0.000147	CcSEcCtD
Alendronate—ATP6V1A—Disease—BAD—hematologic cancer	8.24e-05	0.000371	CbGpPWpGaD
Alendronate—Chest pain—Doxorubicin—hematologic cancer	8.19e-05	0.000147	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—hematologic cancer	8.19e-05	0.000147	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—KITLG—hematologic cancer	8.19e-05	0.000368	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOTCH1—hematologic cancer	8.16e-05	0.000367	CbGpPWpGaD
Alendronate—Nausea—Triamcinolone—hematologic cancer	8.16e-05	0.000146	CcSEcCtD
Alendronate—Discomfort—Doxorubicin—hematologic cancer	8.09e-05	0.000145	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—STAT5A—hematologic cancer	8e-05	0.00036	CbGpPWpGaD
Alendronate—Hypersensitivity—Prednisone—hematologic cancer	7.99e-05	0.000143	CcSEcCtD
Alendronate—ATP6V1A—Disease—CD80—hematologic cancer	7.99e-05	0.00036	CbGpPWpGaD
Alendronate—Dyspepsia—Methotrexate—hematologic cancer	7.98e-05	0.000143	CcSEcCtD
Alendronate—ATP6V1A—Disease—KIT—hematologic cancer	7.98e-05	0.000359	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.94e-05	0.000357	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN2B—hematologic cancer	7.93e-05	0.000357	CbGpPWpGaD
Alendronate—Vomiting—Dexamethasone—hematologic cancer	7.92e-05	0.000142	CcSEcCtD
Alendronate—Vomiting—Betamethasone—hematologic cancer	7.92e-05	0.000142	CcSEcCtD
Alendronate—Rash—Betamethasone—hematologic cancer	7.86e-05	0.000141	CcSEcCtD
Alendronate—Rash—Dexamethasone—hematologic cancer	7.86e-05	0.000141	CcSEcCtD
Alendronate—Dermatitis—Betamethasone—hematologic cancer	7.85e-05	0.00014	CcSEcCtD
Alendronate—Dermatitis—Dexamethasone—hematologic cancer	7.85e-05	0.00014	CcSEcCtD
Alendronate—ATP6V1A—Disease—PTPN11—hematologic cancer	7.84e-05	0.000353	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—hematologic cancer	7.83e-05	0.000352	CbGpPWpGaD
Alendronate—Headache—Betamethasone—hematologic cancer	7.81e-05	0.00014	CcSEcCtD
Alendronate—Headache—Dexamethasone—hematologic cancer	7.81e-05	0.00014	CcSEcCtD
Alendronate—Infection—Doxorubicin—hematologic cancer	7.8e-05	0.00014	CcSEcCtD
Alendronate—Asthenia—Prednisone—hematologic cancer	7.79e-05	0.000139	CcSEcCtD
Alendronate—Pain—Methotrexate—hematologic cancer	7.76e-05	0.000139	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.73e-05	0.000138	CcSEcCtD
Alendronate—Pruritus—Prednisone—hematologic cancer	7.68e-05	0.000137	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CD86—hematologic cancer	7.67e-05	0.000345	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CREB1—hematologic cancer	7.59e-05	0.000342	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.57e-05	0.000341	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HES1—hematologic cancer	7.57e-05	0.000341	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NCOR1—hematologic cancer	7.52e-05	0.000339	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BRAF—hematologic cancer	7.5e-05	0.000337	CbGpPWpGaD
Alendronate—Feeling abnormal—Methotrexate—hematologic cancer	7.47e-05	0.000134	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—hematologic cancer	7.47e-05	0.000134	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGF1—hematologic cancer	7.44e-05	0.000335	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CSF2—hematologic cancer	7.44e-05	0.000335	CbGpPWpGaD
Alendronate—Diarrhoea—Prednisone—hematologic cancer	7.42e-05	0.000133	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—hematologic cancer	7.42e-05	0.000133	CcSEcCtD
Alendronate—FDPS—Metabolism—ABCB1—hematologic cancer	7.41e-05	0.000333	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6R—hematologic cancer	7.41e-05	0.000333	CbGpPWpGaD
Alendronate—Nausea—Betamethasone—hematologic cancer	7.4e-05	0.000132	CcSEcCtD
Alendronate—Nausea—Dexamethasone—hematologic cancer	7.4e-05	0.000132	CcSEcCtD
Alendronate—ATP6V1A—Disease—CREBBP—hematologic cancer	7.4e-05	0.000333	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FOXO1—hematologic cancer	7.33e-05	0.00033	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFRB—hematologic cancer	7.32e-05	0.000329	CbGpPWpGaD
Alendronate—Pain—Epirubicin—hematologic cancer	7.26e-05	0.00013	CcSEcCtD
Alendronate—Constipation—Epirubicin—hematologic cancer	7.26e-05	0.00013	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PDGFRA—hematologic cancer	7.2e-05	0.000324	CbGpPWpGaD
Alendronate—Urticaria—Methotrexate—hematologic cancer	7.2e-05	0.000129	CcSEcCtD
Alendronate—FDPS—Metabolism—GSTM1—hematologic cancer	7.19e-05	0.000324	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOR1—hematologic cancer	7.19e-05	0.000324	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCG—hematologic cancer	7.18e-05	0.000323	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAK1—hematologic cancer	7.18e-05	0.000323	CbGpPWpGaD
Alendronate—Dizziness—Prednisone—hematologic cancer	7.18e-05	0.000128	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—hematologic cancer	7.17e-05	0.000128	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—hematologic cancer	7.17e-05	0.000128	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.15e-05	0.000128	CcSEcCtD
Alendronate—ATP6V1A—Disease—MAP2K1—hematologic cancer	7.06e-05	0.000318	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CD—hematologic cancer	7.01e-05	0.000316	CbGpPWpGaD
Alendronate—Feeling abnormal—Epirubicin—hematologic cancer	6.99e-05	0.000125	CcSEcCtD
Alendronate—Gastrointestinal pain—Epirubicin—hematologic cancer	6.94e-05	0.000124	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—hematologic cancer	6.91e-05	0.000124	CcSEcCtD
Alendronate—Vomiting—Prednisone—hematologic cancer	6.9e-05	0.000123	CcSEcCtD
Alendronate—Rash—Prednisone—hematologic cancer	6.84e-05	0.000122	CcSEcCtD
Alendronate—Dermatitis—Prednisone—hematologic cancer	6.84e-05	0.000122	CcSEcCtD
Alendronate—Headache—Prednisone—hematologic cancer	6.8e-05	0.000122	CcSEcCtD
Alendronate—Urticaria—Epirubicin—hematologic cancer	6.74e-05	0.000121	CcSEcCtD
Alendronate—Pain—Doxorubicin—hematologic cancer	6.72e-05	0.00012	CcSEcCtD
Alendronate—Constipation—Doxorubicin—hematologic cancer	6.72e-05	0.00012	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF2—hematologic cancer	6.71e-05	0.000302	CbGpPWpGaD
Alendronate—Abdominal pain—Epirubicin—hematologic cancer	6.71e-05	0.00012	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—hematologic cancer	6.71e-05	0.00012	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—IL2RA—hematologic cancer	6.71e-05	0.000302	CbGpPWpGaD
Alendronate—Hypersensitivity—Methotrexate—hematologic cancer	6.68e-05	0.00012	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—TERT—hematologic cancer	6.63e-05	0.000298	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3R1—hematologic cancer	6.62e-05	0.000298	CbGpPWpGaD
Alendronate—Asthenia—Methotrexate—hematologic cancer	6.51e-05	0.000116	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PDGFB—hematologic cancer	6.47e-05	0.000291	CbGpPWpGaD
Alendronate—Feeling abnormal—Doxorubicin—hematologic cancer	6.47e-05	0.000116	CcSEcCtD
Alendronate—Nausea—Prednisone—hematologic cancer	6.45e-05	0.000115	CcSEcCtD
Alendronate—ATP6V1A—Disease—JAK2—hematologic cancer	6.44e-05	0.00029	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.42e-05	0.000115	CcSEcCtD
Alendronate—Pruritus—Methotrexate—hematologic cancer	6.42e-05	0.000115	CcSEcCtD
Alendronate—FDPS—Metabolism—MTHFR—hematologic cancer	6.36e-05	0.000286	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TSC2—hematologic cancer	6.33e-05	0.000285	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MDM2—hematologic cancer	6.28e-05	0.000283	CbGpPWpGaD
Alendronate—Hypersensitivity—Epirubicin—hematologic cancer	6.25e-05	0.000112	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—hematologic cancer	6.24e-05	0.000112	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—hematologic cancer	6.21e-05	0.000111	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—hematologic cancer	6.21e-05	0.000111	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—hematologic cancer	6.21e-05	0.000111	CcSEcCtD
Alendronate—ATP6V1A—Disease—MTOR—hematologic cancer	6.11e-05	0.000275	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CB—hematologic cancer	6.11e-05	0.000275	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD4—hematologic cancer	6.1e-05	0.000275	CbGpPWpGaD
Alendronate—Asthenia—Epirubicin—hematologic cancer	6.09e-05	0.000109	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGFR3—hematologic cancer	6.08e-05	0.000274	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK14—hematologic cancer	6.02e-05	0.000271	CbGpPWpGaD
Alendronate—Pruritus—Epirubicin—hematologic cancer	6e-05	0.000107	CcSEcCtD
Alendronate—Dizziness—Methotrexate—hematologic cancer	6e-05	0.000107	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—hematologic cancer	5.91e-05	0.000266	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FN1—hematologic cancer	5.84e-05	0.000263	CbGpPWpGaD
Alendronate—Diarrhoea—Epirubicin—hematologic cancer	5.81e-05	0.000104	CcSEcCtD
Alendronate—Hypersensitivity—Doxorubicin—hematologic cancer	5.79e-05	0.000104	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—BAD—hematologic cancer	5.77e-05	0.00026	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKBIA—hematologic cancer	5.77e-05	0.00026	CbGpPWpGaD
Alendronate—Vomiting—Methotrexate—hematologic cancer	5.77e-05	0.000103	CcSEcCtD
Alendronate—ATP6V1A—Disease—CDKN1B—hematologic cancer	5.74e-05	0.000258	CbGpPWpGaD
Alendronate—Rash—Methotrexate—hematologic cancer	5.72e-05	0.000102	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—hematologic cancer	5.71e-05	0.000102	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH1—hematologic cancer	5.71e-05	0.000257	CbGpPWpGaD
Alendronate—Headache—Methotrexate—hematologic cancer	5.68e-05	0.000102	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—hematologic cancer	5.63e-05	0.000101	CcSEcCtD
Alendronate—Dizziness—Epirubicin—hematologic cancer	5.61e-05	0.0001	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.6e-05	0.000252	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CD80—hematologic cancer	5.6e-05	0.000252	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—hematologic cancer	5.59e-05	0.000251	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KIT—hematologic cancer	5.59e-05	0.000251	CbGpPWpGaD
Alendronate—Pruritus—Doxorubicin—hematologic cancer	5.56e-05	9.94e-05	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTPN11—hematologic cancer	5.49e-05	0.000247	CbGpPWpGaD
Alendronate—Vomiting—Epirubicin—hematologic cancer	5.4e-05	9.65e-05	CcSEcCtD
Alendronate—Nausea—Methotrexate—hematologic cancer	5.39e-05	9.64e-05	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—hematologic cancer	5.37e-05	9.61e-05	CcSEcCtD
Alendronate—Rash—Epirubicin—hematologic cancer	5.35e-05	9.57e-05	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—hematologic cancer	5.35e-05	9.56e-05	CcSEcCtD
Alendronate—FDPS—Metabolism—PIK3CG—hematologic cancer	5.34e-05	0.00024	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREB1—hematologic cancer	5.32e-05	0.000239	CbGpPWpGaD
Alendronate—Headache—Epirubicin—hematologic cancer	5.32e-05	9.51e-05	CcSEcCtD
Alendronate—ATP6V1A—Disease—CDKN1A—hematologic cancer	5.29e-05	0.000238	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTEN—hematologic cancer	5.28e-05	0.000238	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BRAF—hematologic cancer	5.25e-05	0.000236	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL2—hematologic cancer	5.2e-05	0.000234	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—hematologic cancer	5.19e-05	9.29e-05	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—IL6R—hematologic cancer	5.19e-05	0.000233	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREBBP—hematologic cancer	5.18e-05	0.000233	CbGpPWpGaD
Alendronate—Nausea—Epirubicin—hematologic cancer	5.04e-05	9.02e-05	CcSEcCtD
Alendronate—ATP6V1A—Disease—EP300—hematologic cancer	5.04e-05	0.000227	CbGpPWpGaD
Alendronate—Vomiting—Doxorubicin—hematologic cancer	4.99e-05	8.93e-05	CcSEcCtD
Alendronate—FDPS—Metabolism—CREBBP—hematologic cancer	4.95e-05	0.000223	CbGpPWpGaD
Alendronate—Rash—Doxorubicin—hematologic cancer	4.95e-05	8.86e-05	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—hematologic cancer	4.95e-05	8.85e-05	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—MAP2K1—hematologic cancer	4.94e-05	0.000222	CbGpPWpGaD
Alendronate—Headache—Doxorubicin—hematologic cancer	4.92e-05	8.8e-05	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CD—hematologic cancer	4.91e-05	0.000221	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—hematologic cancer	4.9e-05	0.00022	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—hematologic cancer	4.72e-05	0.000213	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NRAS—hematologic cancer	4.71e-05	0.000212	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF2—hematologic cancer	4.7e-05	0.000212	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CD—hematologic cancer	4.7e-05	0.000211	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—hematologic cancer	4.66e-05	8.34e-05	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PIK3R1—hematologic cancer	4.64e-05	0.000209	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—hematologic cancer	4.64e-05	0.000209	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK3—hematologic cancer	4.51e-05	0.000203	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAK2—hematologic cancer	4.51e-05	0.000203	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3R1—hematologic cancer	4.43e-05	0.0002	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MDM2—hematologic cancer	4.4e-05	0.000198	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—hematologic cancer	4.39e-05	0.000198	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—hematologic cancer	4.38e-05	0.000197	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CB—hematologic cancer	4.28e-05	0.000193	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MTOR—hematologic cancer	4.28e-05	0.000193	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CB—hematologic cancer	4.09e-05	0.000184	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—hematologic cancer	4.06e-05	0.000183	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1B—hematologic cancer	4.02e-05	0.000181	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—hematologic cancer	3.94e-05	0.000177	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL2—hematologic cancer	3.93e-05	0.000177	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—hematologic cancer	3.83e-05	0.000172	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—hematologic cancer	3.82e-05	0.000172	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—hematologic cancer	3.73e-05	0.000168	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1A—hematologic cancer	3.71e-05	0.000167	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTEN—hematologic cancer	3.7e-05	0.000166	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—hematologic cancer	3.62e-05	0.000163	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTEN—hematologic cancer	3.54e-05	0.000159	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EP300—hematologic cancer	3.53e-05	0.000159	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—hematologic cancer	3.45e-05	0.000155	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—hematologic cancer	3.43e-05	0.000154	CbGpPWpGaD
Alendronate—FDPS—Metabolism—EP300—hematologic cancer	3.37e-05	0.000152	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—hematologic cancer	3.34e-05	0.00015	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—hematologic cancer	3.31e-05	0.000149	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRAS—hematologic cancer	3.3e-05	0.000149	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—hematologic cancer	3.3e-05	0.000149	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK3—hematologic cancer	3.16e-05	0.000142	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—hematologic cancer	3.07e-05	0.000138	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—hematologic cancer	3.07e-05	0.000138	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—hematologic cancer	3.04e-05	0.000137	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—hematologic cancer	2.84e-05	0.000128	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—hematologic cancer	2.61e-05	0.000117	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—hematologic cancer	2.52e-05	0.000114	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—hematologic cancer	2.49e-05	0.000112	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—hematologic cancer	2.41e-05	0.000109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—hematologic cancer	2.31e-05	0.000104	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—hematologic cancer	2.13e-05	9.59e-05	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—hematologic cancer	2.04e-05	9.17e-05	CbGpPWpGaD
